November 19, 2020 7:26 AM
The University of Oxford will begin an initial analysis of data from the final stage of the trial of the experimental covid-19 vaccine it is developing with AstraZeneca after detecting 53 infections among its volunteers, said on Thursday (November 19th). principal investigator of the study. 2020.
Oxford Vaccine Group director Andrew Pollard said there were “numerous cases” of phase III infections from his trial in the UK, Brazil and South Africa.
The first two interim datasets from Pfizer and BioNTech’s vaccine trials last week and Moderna on Monday, November 16, were released after more than 90 infections in volunteers.
Was this news helpful to you ?: